In Hypertension (high blood pressure) Envas Injection reduces stress on the heart and relaxes the blood vessels. This widens the blood vessels and makes it easier for the heart to pump blood around your body, thereby lowering your blood pressure. Controlled blood pressure reduces the risk of having a heart attack, stroke, or kidney problems. The medicine must be taken regularly, as prescribed, to be effective. You do not usually feel immediate benefit from taking this medicine, however, it helps you maintain your blood pressure in the long term. In Heart failure Envas Injection makes it easier for your heart to pump blood around your body so the heart has to do less work. This can improve your heart function and reduce the symptoms of heart failure. It will help improve your quality of life and enable you to go about your daily activities more efficiently. The medicine is given by a doctor or nurse and must be taken regularly and as long as the doctor has prescribed it to be effective.
It is not known whether it is safe to consume alcohol with Envas Injection. Please consult your doctor.
Information regarding the use of Envas Injection during pregnancy is not available. Please consult your doctor.
Information regarding the use of Envas Injection during breastfeeding is not available. Please consult your doctor.
It is not known whether Envas Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Envas Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Envas Injection in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More